Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eulalie Courcelles

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Frontiers in Medical Technology|March 14, 2022
Solving the Evidence Interpretability Crisis in Health Technology Assessment: A Role for Mechanistic Models?Eulalie Courcelles, Jean-Pierre Boissel, Jacques Massol, et al.
Scientific Reports|November 8, 2024
Multi-strain modeling of influenza vaccine effectiveness in older adults and its dependence on antigenic distanceSéverine Urdy, Matthias Hanke, Ana I Toledo, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 13, 2023
In Silico Clinical Trials: Is It Possible?Simon Arsène, Yves Parès, Eliott Tixier, et al.
NPJ Digital Medicine|March 20, 2025
Credibility assessment of a mechanistic model of atherosclerosis to predict cardiovascular outcomes under lipid-lowering therapyYishu Wang, Eulalie Courcelles, Emmanuel Peyronnet, et al.
European Journal of Preventive Cardiology|December 26, 2025
Prediction of inclisiran efficacy in patients with established atherosclerotic cardiovascular disease: the SIRIUS In-Silico modelling of cardiovascular outcomesDenis Angoulvant, Emmanuel Peyronnet, Bertrand Cariou, et al.
IEEE Journal of Biomedical and Health Informatics|June 23, 2021
Possible Contexts of Use for In Silico Trials Methodologies: A Consensus-Based ReviewMarco Viceconti, Luca Emili, Payman Afshari, et al.
European Journal of Preventive Cardiology|August 5, 2024
In-silico trial emulation to predict the cardiovascular protection of new lipid-lowering drugs: an illustration through the design of the SIRIUS programmeDenis Angoulvant, Solène Granjeon-Noriot, Pierre Amarenco, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 8, 2021
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibilityFlora T Musuamba, Ine Skottheim Rusten, Raphaëlle Lesage, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Frontiers in Medical Technology|March 14, 2022
Solving the Evidence Interpretability Crisis in Health Technology Assessment: A Role for Mechanistic Models?Eulalie Courcelles, Jean-Pierre Boissel, Jacques Massol, et al.
Scientific Reports|November 8, 2024
Multi-strain modeling of influenza vaccine effectiveness in older adults and its dependence on antigenic distanceSéverine Urdy, Matthias Hanke, Ana I Toledo, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 13, 2023
In Silico Clinical Trials: Is It Possible?Simon Arsène, Yves Parès, Eliott Tixier, et al.
NPJ Digital Medicine|March 20, 2025
Credibility assessment of a mechanistic model of atherosclerosis to predict cardiovascular outcomes under lipid-lowering therapyYishu Wang, Eulalie Courcelles, Emmanuel Peyronnet, et al.
European Journal of Preventive Cardiology|December 26, 2025
Prediction of inclisiran efficacy in patients with established atherosclerotic cardiovascular disease: the SIRIUS In-Silico modelling of cardiovascular outcomesDenis Angoulvant, Emmanuel Peyronnet, Bertrand Cariou, et al.
IEEE Journal of Biomedical and Health Informatics|June 23, 2021
Possible Contexts of Use for In Silico Trials Methodologies: A Consensus-Based ReviewMarco Viceconti, Luca Emili, Payman Afshari, et al.
European Journal of Preventive Cardiology|August 5, 2024
In-silico trial emulation to predict the cardiovascular protection of new lipid-lowering drugs: an illustration through the design of the SIRIUS programmeDenis Angoulvant, Solène Granjeon-Noriot, Pierre Amarenco, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 8, 2021
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibilityFlora T Musuamba, Ine Skottheim Rusten, Raphaëlle Lesage, et al.
Pageof 1